M4-PAM

N/A

Report date: 2025/01/26 18:50:36
NME

Base Information

Drug NameM4-PAM
Drug Alias NameMuscarinic Acetylcholine Receptor Subtype 4 Positive Allosteric Modulator (Addex Therapeutics)M4-PAM
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M4 modulators
TargetsMuscarinic acetylcholine receptor M4
Therapy Area/IndicationsSchizophreniaPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAddex Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaPsychotic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A